International journal of clinical oncology, 2020-09, Vol.25 (9), p.1744-1745
- Hishiki, Tomoro
- Matsumoto, Kimikazu
- Ohira, Miki
- Kamijo, Takehiko
- Shichino, Hiroyuki
- Kuroda, Tatsuo
- Yoneda, Akihiro
- Soejima, Toshinori
- Nakazawa, Atsuko
- Takimoto, Tetsuya
- Yokota, Isao
- Teramukai, Satoshi
- Takahashi, Hideto
- Fukushima, Takashi
- Kaneko, Takashi
- Hara, Junichi
- Kaneko, Michio
- Ikeda, Hitoshi
- Tajiri, Tatsuro
- Nakagawara, Akira
2020
Details
- Autor(en) / Beteiligte
- Hishiki, Tomoro
- Matsumoto, Kimikazu
- Ohira, Miki
- Kamijo, Takehiko
- Shichino, Hiroyuki
- Kuroda, Tatsuo
- Yoneda, Akihiro
- Soejima, Toshinori
- Nakazawa, Atsuko
- Takimoto, Tetsuya
- Yokota, Isao
- Teramukai, Satoshi
- Takahashi, Hideto
- Fukushima, Takashi
- Kaneko, Takashi
- Hara, Junichi
- Kaneko, Michio
- Ikeda, Hitoshi
- Tajiri, Tatsuro
- Nakagawara, Akira
- Titel
- Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)
- Ist Teil von
- International journal of clinical oncology, 2020-09, Vol.25 (9), p.1744-1745
- Ort / Verlag
- Singapore: Springer Singapore
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- SpringerNature Journals
- Beschreibungen/Notizen
- In the October 2018 issue of International Journal of Clinical Oncology.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1341-9625eISSN: 1437-7772DOI: 10.1007/s10147-020-01752-4Titel-ID: cdi_proquest_miscellaneous_2430377602
- Format
- –
- Schlagworte
- Cancer Research, Children, Correction, Medicine, Medicine & Public Health, Neuroblastoma, Oncology, Surgical Oncology